Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases

NCT06427642 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
120
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shandong Qilu Stem Cells Engineering Co., Ltd.

Collaborators